Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Functional bracing treatment for stable type B ankle fractures.

van den Berg C, Haak T, Weil NL, Hoogendoorn JM.

Injury. 2018 Jun 4. pii: S0020-1383(18)30280-8. doi: 10.1016/j.injury.2018.06.009. [Epub ahead of print]

PMID:
29903578
2.

[The five most common errors in insulin therapy].

Haak T.

MMW Fortschr Med. 2018 Jun;160(11):41-43. doi: 10.1007/s15006-018-0627-5. Review. German. No abstract available.

PMID:
29892855
3.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections.

Haak T.

Ann Intern Med. 2018 Apr 3;168(7):525-526. doi: 10.7326/L17-0705. No abstract available.

PMID:
29610904
4.

Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes.

Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, Haak T, Hermanns N.

Psychoneuroendocrinology. 2018 May;91:216-225. doi: 10.1016/j.psyneuen.2018.02.032. Epub 2018 Mar 6.

PMID:
29525039
5.

Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores.

Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, Haak T, Hermanns N.

Transl Psychiatry. 2018 Mar 9;7(11):1. doi: 10.1038/s41398-017-0009-2.

PMID:
29520075
6.

Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.

Danne T, Schwandt A, Biester T, Heidtmann B, Rami-Merhar B, Haberland H, Müther S, Khodaverdi S, Haak T, Holl RW; DPV Initiative.

Pediatr Diabetes. 2018 Aug;19(5):979-984. doi: 10.1111/pedi.12658. Epub 2018 Apr 15.

PMID:
29446511
7.

The additional value of gravity stress radiographs in predicting deep deltoid ligament integrity in supination external rotation ankle fractures.

van Leeuwen C, Haak T, Kop M, Weil N, Zijta F, Hoogendoorn J.

Eur J Trauma Emerg Surg. 2018 Feb 13. doi: 10.1007/s00068-018-0923-x. [Epub ahead of print]

PMID:
29441406
8.

Measurement of psychological adjustment to diabetes with the diabetes acceptance scale.

Schmitt A, Reimer A, Kulzer B, Icks A, Paust R, Roelver KM, Kaltheuner M, Ehrmann D, Krichbaum M, Haak T, Hermanns N.

J Diabetes Complications. 2018 Apr;32(4):384-392. doi: 10.1016/j.jdiacomp.2018.01.005. Epub 2018 Jan 31.

PMID:
29439862
10.

Adherence Over Time: The Course of Adherence to Customized Diabetic Insoles as Objectively Assessed by a Temperature Sensor.

Ehrmann D, Spengler M, Jahn M, Niebuhr D, Haak T, Kulzer B, Hermanns N.

J Diabetes Sci Technol. 2018 May;12(3):695-700. doi: 10.1177/1932296817747618. Epub 2017 Dec 27.

PMID:
29281893
11.

NBAS mutations cause acute liver failure: when acetaminophen is not a culprit.

Calvo PL, Tandoi F, Haak TB, Brunati A, Pinon M, Olio DD, Romagnoli R, Spada M.

Ital J Pediatr. 2017 Sep 25;43(1):88. doi: 10.1186/s13052-017-0406-4.

12.

Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study.

Schmitt A, Reimer A, Ehrmann D, Kulzer B, Haak T, Hermanns N.

J Diabetes Complications. 2017 Nov;31(11):1608-1613. doi: 10.1016/j.jdiacomp.2017.08.004. Epub 2017 Aug 9.

PMID:
28865713
13.

The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes.

Ehrmann D, Schmitt A, Reimer A, Haak T, Kulzer B, Hermanns N.

Acta Diabetol. 2017 Aug;54(8):749-756. doi: 10.1007/s00592-017-1006-x. Epub 2017 May 29.

PMID:
28555338
14.

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P.

Diabetes Technol Ther. 2017 Jul;19(7):391-399. doi: 10.1089/dia.2017.0054. Epub 2017 May 22. Review.

15.

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.

Owens DR, Bolli GB, Charbonnel B, Haak T, Landgraf W, Porcellati F, Traylor L, Kautzky-Willer A.

Diabetes Obes Metab. 2017 Nov;19(11):1546-1554. doi: 10.1111/dom.12966. Epub 2017 Jul 27.

PMID:
28449412
16.

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G.

Diabetes Ther. 2017 Jun;8(3):573-586. doi: 10.1007/s13300-017-0255-6. Epub 2017 Apr 11.

17.

The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.

Hermanns N, Ehrmann D, Schall S, Maier B, Haak T, Kulzer B.

Diabet Med. 2017 Aug;34(8):1084-1091. doi: 10.1111/dme.13346. Epub 2017 Apr 2.

PMID:
28257159
18.

Depression is linked to hyperglycaemia via suboptimal diabetes self-management: A cross-sectional mediation analysis.

Schmitt A, Reimer A, Hermanns N, Kulzer B, Ehrmann D, Krichbaum M, Huber J, Haak T.

J Psychosom Res. 2017 Mar;94:17-23. doi: 10.1016/j.jpsychores.2016.12.015. Epub 2016 Dec 29.

PMID:
28183398
19.

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G.

Diabetes Ther. 2017 Feb;8(1):55-73. doi: 10.1007/s13300-016-0223-6. Epub 2016 Dec 20.

20.

Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation.

Ehrmann D, Hermanns N, Reimer A, Weißmann J, Haak T, Kulzer B.

Diabetes Technol Ther. 2016 Mar;18(3):194-9. doi: 10.1089/dia.2015.0292. Epub 2016 Feb 23.

PMID:
26907638

Supplemental Content

Support Center